CatalystWireBeta

UK small-cap RNS · 29 May 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 14:03
    Result of Retail Offer and Update on Timing Fundraise
    Retail offer closed at about £0.5m, half the £1m maximum, at 80p. It dilutes holders and only completes if the refinancing does, which is still unresolved.
    Balance-sheet stress / refinancing £0.5m · 5% of mcap +0.0% on the day
    Moved: Refinancing and liquidity fundraising: Conditional fundraising; retail tranche opened, refinancing outstanding → Fundraise closed; refinancing still unconfirmed
  2. 12:46
    Business Update
    Tender prices fell sharply in April-May (Cullinan c. $81/ct, Finsch c. $47/ct) and the company sees no near-term recovery in small stones. Guidance stays suspended, and Finsch goes into business rescue.
    Balance-sheet stress / refinancing outlook negative, lowered −18.9% on the day
    Moved: Finsch financial review: Assessment under way; no decision taken → Business rescue commenced; practitioner not yet appointed · Balance-sheet leverage: RCF fully drawn; liquidity preservation under way → Covenant waivers sought; liquidity breach anticipated · Updated business plan execution: Cullinan plan being revised; carat guidance suspended → Guidance suspended; plan due end September 2026
  3. 11:56
    Director/PDMR Shareholding Director dealing
  4. 09:03
    Audited Final Results for Year Ended 31 Jan 2026 Results
    Audited FY to January 2026 results show resource upgrades at Hussar and Mt Winter, the $25m Harlequin funding and a signed rig contract, but the company is pre-revenue and the Central Petroleum deal has fallen away.
    Project milestones outlook positivefirst in 7 months +10.7% on the day
    Moved: Complete the audit of the 2025 annual report by 30 June 2025: pending → delivered – Audited results for the year to 31 January 2026 were published on 29 May 2026 with an auditor's report. · Hussar well drilling approvals: Rig contract executed; supplier selection under way → Rig contracted; suppliers still to be agreed · Mt Winter tenement acquisition: CEO describes purchase as completed → Subject to completion; ALRA draft under review
  5. 07:00
    Acquires Strategic Surface Land at Topaz Project
    Buys about 1,360 acres of surface land over its leased Topaz minerals, including the Jetstream #7 site, for US$2.48m cash. This secures siting and operational control ahead of production. It uses existing cash.
    Project milestones outlook positive +5.0% on the day
    Moved: Topaz multi-well drilling campaign: Appraisal complete; production-well planning → Appraisal complete; production-well planning; surface land secured
  6. 07:00
    1MW MFE220 Factory Acceptance Test update
    The incident during final FAT damaged the 1MW unit and will materially delay completion, which was expected in May 2026. This undermines the Q3 2026 site acceptance and first revenue timetable.
    Project milestones outlook negative, loweredfirst since Oct 2023 +0.0% on the day
    Moved: MFE220 1MW testing and on-site operation: FAT level 2 signed off; at test site → Final FAT incident; unit damaged, operations suspended · new: Liquidity and funding shortfall – Raise paused; shares suspended · new: Insurance and customer contract impact – Under review
  7. 07:00
    Director/PDMR Shareholding Director dealing
  8. 07:00
    Final Results Results
    Pre-revenue explorer posts a narrower FY2025 loss (€1.08m vs €1.74m) but cash was only €0.07m at year-end; post-period £3.25m raise funds the tungsten drilling, so the story stays on Defender-Pine Crow.
    Project milestones outlook positivefirst in 8 months +10.8% on the day
    Moved: Pine Crow-Defender tungsten exploration: Major exploration campaign under way → Drilling contractor secured; mapping and gravity under way · Eastside-Tango option to KGHM: Option agreement signed; six-year option period → Option signed; KGHM can earn 100% over time · Placing admission and warrants: Conditionally raised, awaiting admission → Funds raised; warrant exercises add to proceeds
  9. 07:00
    MSA with Global Pharmaceutical Company
    Qualifies the company as a service provider to AstraZeneca. This looks like the top-ten pharma MSA the company said was in its final stages, supporting the FY2026 target, but no order value or volumes are given.
    Turnaround plan with targets first in 6 months +24.6% on the day
    Moved: Restructuring and turnaround: Restructure advancing; first FY2026 revenue target set → Pharma MSA signed; FY2026 revenue target stands
  10. 07:00
    Orom Cross Graphite DFS NPV10 up 15% to US$1.254bn
    Updated DFS model lifts NPV10 15% to US$1.254bn and net free cash 120% with capex unchanged, delivering the update promised in the 26 May interims. IRR falls to 51% and financing is still open.
    Project milestones outlook positive +2.0% on the day
    Moved: Orom-Cross DFS and JORC update: DFS update pending; P1 financing in due diligence → Updated DFS out; P1 equity in due diligence

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note